VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
-8.11%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$188M
AUM Growth
+$188M
(+123%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
54.93%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$115M |
Top Sells
| 1 |
CBAY
Cymabay Therapeutics
CBAY
|
$5.95M |
| 2 |
UTRS
Minerva Surgical, Inc. Common Stock
UTRS
|
$5.23M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RYZB
1
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $115M | 60.87% | +5,158,161 | New | +$115M |
|
2
Repare Therapeutics
RPTX
$71.7M
| $32M | 17% | 2,646,657 | – | – |
|
3
CRISPR Therapeutics
CRSP
$4.71B
| $22.6M | 12.03% | 498,558 | – | – |
|
4
Adverum Biotechnologies
ADVM
$64.6M
| $7.6M | 4.04% | 5,068,233 | – | – |
|
|
GRTS
5
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $6.13M | 3.26% | 3,561,150 | – | – |
|
6
Passage Bio
PASG
$22.7M
| $3.26M | 1.73% | 4,959,769 | – | – |
|
7
Aligos Therapeutics
ALGS
$73.3M
| $1.73M | 0.92% | 2,320,381 | – | – |
|
|
UTRS
8
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
| $275K | 0.15% | 83,684 -1,590,016 | -95% | -$5.23M |
|
|
CBAY
9
DELISTED
Cymabay Therapeutics
CBAY
| – | – | -543,753 | Closed | -$5.95M |
|